Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Neumann

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Cancers|May 16, 2023
Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients-A Single-Center Analysis of 1294 Patients within the Last DecadeChristopher C M Neumann, François Schneider, Georg Hilfenhaus, et al.
Cancers|March 28, 2024
Cachexia-Affected Survival Based on Inflammatory Parameters Compared to Complex Conventional Nutritional Assessments in Patients with Pancreatic Cancer and Other Gastrointestinal Tumors-The CONKO 020 InvestigationJohanna W Meyer-Knees, Janina Falkenthal, Dominik Geisel, et al.
Journal of Clinical Medicine|August 26, 2022
Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer-The CONKO-008 Phase I InvestigationJana K Striefler, Jens M Stieler, Christopher C M Neumann, et al.
World Journal of Urology|April 15, 2024
Individualized center-based analysis of urinary and sexual functional outcome after radical prostatectomy based on the prostate cancer outcome study: a post hoc pathway to patient outcome measurement analysis for quality improvementGregor Duwe, Katharina Boehm, Gerrit Becker, et al.
Scientific Reports|April 14, 2026
Impact of culture dimensionality and matrix composition on morphology, phenotype and drug response in pancreatic cancer modelsFlorian Doelvers, Katharina Wansch, Anna Kuehn, et al.
Cancer Medicine|December 30, 2025
Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational StudyKatharina Wansch, François Schneider, Florian Dölvers, et al.
European Journal of Cancer (Oxford, England : 1990)|December 30, 2025
The basis for future personalized therapy approaches - Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patientsFrançois Schneider, Haotian Chen, Uwe Pelzer, et al.
World Journal of Urology|September 30, 2024
Radical cystectomy in patients aged < 80 years versus ≥ 80 years: analysis of preoperative geriatric assessment scores in predicting postoperative morbidity and mortalityGregor Duwe, Isabel Wagner, Katarzyna E Banasiewicz, et al.
Biomedicines|September 28, 2023
Change in Splenic Volume as a Surrogate Marker for Immunotherapy Response in Patients with Advanced Urothelial and Renal Cell Carcinoma-Evaluation of a Novel Approach of Fully Automated Artificial Intelligence Based Splenic SegmentationGregor Duwe, Lukas Müller, Christian Ruckes, et al.
Cancer Cell International|September 13, 2025
Multi-drug pharmacotyping improves therapy prediction in pancreatic cancer organoidsKatharina Wansch, Uwe Pelzer, François Schneider, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Cancers|May 16, 2023
Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients-A Single-Center Analysis of 1294 Patients within the Last DecadeChristopher C M Neumann, François Schneider, Georg Hilfenhaus, et al.
Cancers|March 28, 2024
Cachexia-Affected Survival Based on Inflammatory Parameters Compared to Complex Conventional Nutritional Assessments in Patients with Pancreatic Cancer and Other Gastrointestinal Tumors-The CONKO 020 InvestigationJohanna W Meyer-Knees, Janina Falkenthal, Dominik Geisel, et al.
Journal of Clinical Medicine|August 26, 2022
Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer-The CONKO-008 Phase I InvestigationJana K Striefler, Jens M Stieler, Christopher C M Neumann, et al.
World Journal of Urology|April 15, 2024
Individualized center-based analysis of urinary and sexual functional outcome after radical prostatectomy based on the prostate cancer outcome study: a post hoc pathway to patient outcome measurement analysis for quality improvementGregor Duwe, Katharina Boehm, Gerrit Becker, et al.
Scientific Reports|April 14, 2026
Impact of culture dimensionality and matrix composition on morphology, phenotype and drug response in pancreatic cancer modelsFlorian Doelvers, Katharina Wansch, Anna Kuehn, et al.
Cancer Medicine|December 30, 2025
Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational StudyKatharina Wansch, François Schneider, Florian Dölvers, et al.
European Journal of Cancer (Oxford, England : 1990)|December 30, 2025
The basis for future personalized therapy approaches - Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patientsFrançois Schneider, Haotian Chen, Uwe Pelzer, et al.
World Journal of Urology|September 30, 2024
Radical cystectomy in patients aged < 80 years versus ≥ 80 years: analysis of preoperative geriatric assessment scores in predicting postoperative morbidity and mortalityGregor Duwe, Isabel Wagner, Katarzyna E Banasiewicz, et al.
Biomedicines|September 28, 2023
Change in Splenic Volume as a Surrogate Marker for Immunotherapy Response in Patients with Advanced Urothelial and Renal Cell Carcinoma-Evaluation of a Novel Approach of Fully Automated Artificial Intelligence Based Splenic SegmentationGregor Duwe, Lukas Müller, Christian Ruckes, et al.
Cancer Cell International|September 13, 2025
Multi-drug pharmacotyping improves therapy prediction in pancreatic cancer organoidsKatharina Wansch, Uwe Pelzer, François Schneider, et al.
Pageof 7